CCC
ORKA

Cable Car Capital’s Oruka Therapeutics ORKA Stock Holding History

Cable Car Capital’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200,000
Closed -$9.81M – 224
2026
Q1 		$9.81M Sell
200,000
-200,000
-50% -$6.95M 3.39% 6
2025
Q4 		$12.1M Sell
400,000
-100,000
-20% -$2.79M 0.4% 16
2025
Q3 		$9.62M Sell
500,000
-100,000
-17% -$1.48M 4.12% 4
2025
Q2 		$6.73M Buy
600,000
+150,000
+33% +$1.56M 2.16% 5
2025
Q1 		$4.62M Buy
450,000
+116,629
+35% +$1.45M 5.24% 8
2024
Q4 		$6.46M Hold
333,371
– – 0.25% 37
2024
Q3 		$8.17M Hold
333,371
– – 8.73% 1
2024
Q2 		$15.3M Hold
333,371
– – 16.14% 1
2024
Q1 		$7.04M Hold
333,371
– – 9.73% 1
2023
Q4 		$6.8M Buy
+333,371
New +$7.49M 7.06% 4

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Cable Car Capital's ORKA Position: Q2 2026 in Review

Cable Car Capital sold out of Oruka Therapeutics (ORKA) in Q2 2026, closing a stake of 200,000 shares — an estimated $9.81M sold.

Cable Car Capital first reported a position in ORKA in Q4 2023 and held it in 10 quarters. The position peaked at $15.3M in Q2 2024. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Cable Car Capital reported no remaining Oruka Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Cable Car Capital sold 200,000 Oruka Therapeutics shares in Q2 2026, an estimated $9.81M.
  • Cable Car Capital first reported a position in Oruka Therapeutics in Q4 2023 and held it in 10 quarters.
  • Cable Car Capital's Oruka Therapeutics position peaked at $15.3M in Q2 2024.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Cable Car Capital's 13F filing for Q2 2026, filed 14 Aug 2026.